These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8142297)

  • 41. Preliminary study of the treatment of advanced breast cancer in postmenopausal women with the aromatase inhibitor CGS 16949A.
    Stein RC; Dowsett M; Davenport J; Hedley A; Ford HT; Gazet JC; Coombes RC
    Cancer Res; 1990 Mar; 50(5):1381-4. PubMed ID: 2137367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
    Santen RJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aromatase inhibition by the antifungal ketoconazole.
    Wouters W; De Coster R; Goeminne N; Beerens D; van Dun J
    J Steroid Biochem; 1988; 30(1-6):387-9. PubMed ID: 3386265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aminoglutethimide and ketoconazole: historical perspectives and future prospects.
    Shaw MA; Nicholls PJ; Smith HJ
    J Steroid Biochem; 1988 Jul; 31(1):137-46. PubMed ID: 2969435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Basic characteristics of rat brain microsomal estradiol 2-hydroxylase].
    Tsukamoto T
    Nihon Naibunpi Gakkai Zasshi; 1990 Mar; 66(3):159-67. PubMed ID: 2347419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated 4-hydroxylation of estradiol by hamster kidney microsomes: a potential pathway of metabolic activation of estrogens.
    Weisz J; Bui QD; Roy D; Liehr JG
    Endocrinology; 1992 Aug; 131(2):655-61. PubMed ID: 1386303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Competitive product inhibition of aromatase by natural estrogens.
    Shimizu Y; Yarborough C; Osawa Y
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):651-6. PubMed ID: 8476777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The xenobiotic inhibitor profile of cytochrome P4502C8.
    Ong CE; Coulter S; Birkett DJ; Bhasker CR; Miners JO
    Br J Clin Pharmacol; 2000 Dec; 50(6):573-80. PubMed ID: 11136296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of aromatase as treatment of breast carcinoma in postmenopausal women.
    Santen RJ; Boucher AE; Santner SJ; Henderson IC; Harvey H; Lipton A
    J Lab Clin Med; 1987 Mar; 109(3):278-89. PubMed ID: 3546561
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disruption of ovarian development in alligator embryos treated with an aromatase inhibitor.
    Lance VA; Bogart MH
    Gen Comp Endocrinol; 1992 Apr; 86(1):59-71. PubMed ID: 1387096
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 2-Bromo- and 16-bromo-estrogens and related compounds: potential inhibitors for both estradiol 2- and 16 alpha-hydroxylases in rat liver microsomes.
    Numazawa M; Satoh S
    J Steroid Biochem; 1989 Jul; 33(1):111-7. PubMed ID: 2761259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of ketoconazole on human ovarian C17,20-desmolase and aromatase.
    Weber MM; Will A; Adelmann B; Engelhardt D
    J Steroid Biochem Mol Biol; 1991 Feb; 38(2):213-8. PubMed ID: 2004042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of cytochrome P-4502C9 in irbesartan oxidation by human liver microsomes.
    Bourrié M; Meunier V; Berger Y; Fabre G
    Drug Metab Dispos; 1999 Feb; 27(2):288-96. PubMed ID: 9929518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blockade of estrogen synthesis with an aromatase inhibitor affects luteal function of the pseudopregnant rat.
    Shetty G; Bhatnagar AS; Moudgal NR
    J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):347-53. PubMed ID: 8541231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
    Santen RJ; Leszczynski D; Tilson-Mallet N; Feil PD; Wright C; Manni A; Santner SJ
    Ann N Y Acad Sci; 1986; 464():126-37. PubMed ID: 3524346
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estrogen metabolism in primary kidney cell cultures from Syrian hamsters.
    Brueggemeier RW; Tseng K; Katlic NE; Beleh MA; Lin YC
    J Steroid Biochem; 1990 Jul; 36(4):325-31. PubMed ID: 2391962
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kinetic properties of aromatase mutants Pro308Phe, Asp309Asn, and Asp309Ala and their interactions with aromatase inhibitors.
    Kadohama N; Yarborough C; Zhou D; Chen S; Osawa Y
    J Steroid Biochem Mol Biol; 1992 Dec; 43(7):693-701. PubMed ID: 1472461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Additive effects of aminoglutethimide, testololactone, and 4-hydroxyandrostenedione as inhibitors of aromatase.
    Santner SJ; Rosen H; Osawa Y; Santen RJ
    J Steroid Biochem; 1984 Jun; 20(6A):1239-42. PubMed ID: 6748639
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kinetics of inhibition of estrogen 2-hydroxylase by various haloestrogens.
    Brueggemeier RW; Kimball JG
    Steroids; 1983 Jul; 42(1):93-103. PubMed ID: 6673180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors.
    Abul-Hajj YJ
    Cancer Res; 1982 Aug; 42(8 Suppl):3373s-3377s. PubMed ID: 6211227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.